Skip to main content
New formulation of Lyrica approved by FDA
10/16/2017

The FDA approved a controlled-release version of Pfizer's Lyrica as a once-daily treatment for diabetic peripheral neuropathy but not for the management of fibromyalgia. The patent on the original formulation expires next December.

Full Story: